Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

Published:2011-08-25 Issue:8 Volume:365 Page:699-708
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Alexander John H.,Lopes Renato D.,James Stefan,Kilaru Rakhi,He Yaohua,Mohan Puneet,Bhatt Deepak L.,Goodman Shaun,Verheugt Freek W.,Flather Marcus,Huber Kurt,Liaw Danny,Husted Steen E.,Lopez-Sendon Jose,De Caterina Raffaele,Jansky Petr,Darius Harald,Vinereanu Dragos,Cornel Jan H.,Cools Frank,Atar Dan,Leiva-Pons Jose Luis,Keltai Matyas,Ogawa Hisao,Pais Prem,Parkhomenko Alexander,Ruzyllo Witold,Diaz Rafael,White Harvey,Ruda Mikhail,Geraldes Margarida,Lawrence Jack,Harrington Robert A.,Wallentin Lars

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1105819

Cited by 886 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the structural and thermodynamic properties of the inclusion complex of apixaban with natural cyclodextrins;Journal of Molecular Structure;2024-12

2. Antithrombotic Therapy in Acute Coronary Syndrome;Interventional Cardiology Clinics;2024-10

3. The impact of early reperfusion therapy using novel pharmacological agents and advanced imaging techniques on mortality and functional outcomes in acute myocardial infarction;South Florida Journal of Health;2024-09-05

4. In-hospital outcomes and postdischarge mortality in patients with acute coronary syndrome and atrial fibrillation;Heart Rhythm;2024-09

5. New interest in fibrinogen as an ischemic risk factor;Journal of Thrombosis and Thrombolysis;2024-08-07